Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa - PubMed (original) (raw)

. 2007 Jun 15;316(5831):1632-4.

doi: 10.1126/science.1139111.

Affiliations

• PMID: 17569869
• DOI: 10.1126/science.1139111

Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa

Umeharu Ohto et al. Science. 2007.

Abstract

Endotoxic lipopolysaccharide (LPS) with potent immunostimulatory activity is recognized by the receptor complex of MD-2 and Toll-like receptor 4. Crystal structures of human MD-2 and its complex with the antiendotoxic tetra-acylated lipid A core of LPS have been determined at 2.0 and 2.2 angstrom resolutions, respectively. MD-2 shows a deep hydrophobic cavity sandwiched by two beta sheets, in which four acyl chains of the ligand are fully confined. The phosphorylated glucosamine moieties are located at the entrance to the cavity. These structures suggest that MD-2 plays a principal role in endotoxin recognition and provide a basis for antiseptic drug development.

PubMed Disclaimer

Comment in

• Immunology. The shape of things to come.
  Fitzgerald KA, Golenbock DT. Fitzgerald KA, et al. Science. 2007 Jun 15;316(5831):1574-6. doi: 10.1126/science.1144483. Science. 2007. PMID: 17569850 No abstract available.

Similar articles

• Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.
  Ohto U, Fukase K, Miyake K, Shimizu T. Ohto U, et al. Proc Natl Acad Sci U S A. 2012 May 8;109(19):7421-6. doi: 10.1073/pnas.1201193109. Epub 2012 Apr 24. Proc Natl Acad Sci U S A. 2012. PMID: 22532668 Free PMC article.
• Crystal structure of mouse MD-1 with endogenous phospholipid bound in its cavity.
  Harada H, Ohto U, Satow Y. Harada H, et al. J Mol Biol. 2010 Jul 23;400(4):838-46. doi: 10.1016/j.jmb.2010.05.063. Epub 2010 Jun 1. J Mol Biol. 2010. PMID: 20595044
• Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
  Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, Enkhbayar P, Matsushima N, Lee H, Yoo OJ, Lee JO. Kim HM, et al. Cell. 2007 Sep 7;130(5):906-17. doi: 10.1016/j.cell.2007.08.002. Cell. 2007. PMID: 17803912
• Structural biology of the LPS recognition.
  Jerala R. Jerala R. Int J Med Microbiol. 2007 Sep;297(5):353-63. doi: 10.1016/j.ijmm.2007.04.001. Epub 2007 May 3. Int J Med Microbiol. 2007. PMID: 17481951 Review.
• Structures of the toll-like receptor family and its ligand complexes.
  Jin MS, Lee JO. Jin MS, et al. Immunity. 2008 Aug 15;29(2):182-91. doi: 10.1016/j.immuni.2008.07.007. Immunity. 2008. PMID: 18701082 Review.

Cited by

• The implication of dendritic cells in lung diseases: Immunological role of toll-like receptor 4.
  Xuan S, Ma Y, Zhou H, Gu S, Yao X, Zeng X. Xuan S, et al. Genes Dis. 2023 Jun 27;11(6):101007. doi: 10.1016/j.gendis.2023.04.036. eCollection 2024 Nov. Genes Dis. 2023. PMID: 39238498 Free PMC article. Review.
• Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.
  Bowen WS, Minns LA, Johnson DA, Mitchell TC, Hutton MM, Evans JT. Bowen WS, et al. Sci Signal. 2012 Feb 14;5(211):ra13. doi: 10.1126/scisignal.2001963. Sci Signal. 2012. PMID: 22337809 Free PMC article.
• Synergy between 15-lipoxygenase and secreted PLA2 promotes inflammation by formation of TLR4 agonists from extracellular vesicles.
  Ha VT, Lainšček D, Gesslbauer B, Jarc-Jovičić E, Hyötyläinen T, Ilc N, Lakota K, Tomšič M, van de Loo FAJ, Bochkov V, Petan T, Jerala R, Manček-Keber M. Ha VT, et al. Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25679-25689. doi: 10.1073/pnas.2005111117. Epub 2020 Sep 24. Proc Natl Acad Sci U S A. 2020. PMID: 32973091 Free PMC article.
• Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase.
  Komazin G, Maybin M, Woodard RW, Scior T, Schwudke D, Schombel U, Gisch N, Mamat U, Meredith TC. Komazin G, et al. J Biol Chem. 2019 Dec 13;294(50):19405-19423. doi: 10.1074/jbc.RA119.010836. Epub 2019 Nov 8. J Biol Chem. 2019. PMID: 31704704 Free PMC article.
• Evidence of a specific interaction between new synthetic antisepsis agents and CD14.
  Piazza M, Yu L, Teghanemt A, Gioannini T, Weiss J, Peri F. Piazza M, et al. Biochemistry. 2009 Dec 29;48(51):12337-44. doi: 10.1021/bi901601b. Biochemistry. 2009. PMID: 19928913 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • H1 Connect
  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • GlyGen glycoinformatics resource